Oncogene - Table of Contents alert Volume 34 Issue 4

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 34, Issue 4 (January 2015) In this issue Review Original Articles Short Communications Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top Targeting RNA polymerase I to treat MYC-driven cancer G Poortinga, L M Quinn and R D Hannan Oncogene 2015 34: 403-412; advance online publication, March 10, 2014; 10.1038/onc.2014.13 Abstract | Full Text Original Articles Top MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway T Yu, J Li, M Yan, L Liu, H Lin, F Zhao, L Sun, Y Zhang, Y Cui, F Zhang, J Li, X He and M Yao Oncogene 2015 34: 413-423; advance online publication, January 27, 2014; 10.1038/onc.2013.574 Abstract | Full Text A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4 M T Hansen, B Forst, N Cremers, L Quagliata, N Ambartsumian, B Grum-Schwensen, J Klingelhöfer, A Abdul-Al, P Herrmann, M Osterland, U Stein, G H Nielsen, P E Scherer, E Lukanidin, J P Sleeman and M Grigorian Oncogene 2015 34: 424-435; advance online publication, January 27, 2014; 10.1038/onc.2013.568 Abstract | Full Text TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis A R Cyr, M V Kulak, J M Park, M V Bogachek, P M Spanheimer, G W Woodfield, L S White-Baer, Y Q O'Malley, S L Sugg, A K Olivier, W Zhang, F E Domann and R J Weigel Oncogene 2015 34: 436-444; advance online publication, January 27, 2014; 10.1038/onc.2013.569 Abstract | Full Text Oncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation A A Sahasrabuddhe, X Chen, F Chung, T Velusamy, M S Lim and K S J Elenitoba-Johnson Oncogene 2015 34: 445-454; advance online publication, January 27, 2014; 10.1038/onc.2013.571 Abstract | Full Text Transcriptional regulation of fibronectin by p21-activated kinase-1 modulates pancreatic tumorigenesis S Jagadeeshan, Y R Krishnamoorthy, M Singhal, A Subramanian, J Mavuluri, A Lakshmi, A Roshini, G Baskar, M Ravi, L D Joseph, K Sadasivan, A Krishnan, A S Nair, G Venkatraman and S K Rayala Oncogene 2015 34: 455-464; advance online publication, February 24, 2014; 10.1038/onc.2013.576 Abstract | Full Text SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms U Bedi, A H Scheel, M Hennion, Y Begus-Nahrmann, J Rüschoff and S A Johnsen Oncogene 2015 34: 465-473; advance online publication, January 20, 2014; 10.1038/onc.2013.558 Abstract | Full Text Casein kinase 1 regulates Sprouty2 in FGF–ERK signaling D G R Yim, S Ghosh, G R Guy and D M Virshup Oncogene 2015 34: 474-484; advance online publication, January 27, 2014; 10.1038/onc.2013.564 Abstract | Full Text Inhibition of ANKRD1 sensitizes human ovarian cancer cells to endoplasmic reticulum stress-induced apoptosis Y Lei, B R Henderson, C Emmanuel, P R Harnett and A deFazio Oncogene 2015 34: 485-495; advance online publication, February 17, 2014; 10.1038/onc.2013.566 Abstract | Full Text KSHV vCyclin counters the senescence/G1 arrest response triggered by NF-κB hyperactivation H Zhi, M A Zahoor, A M D Shudofsky and C-Z Giam Oncogene 2015 34: 496-505; advance online publication, January 27, 2014; 10.1038/onc.2013.567 Abstract | Full Text Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes A R Daniel, A L Gaviglio, T P Knutson, J H Ostrander, A B D'Assoro, P Ravindranathan, Y Peng, G V Raj, D Yee and C A Lange Oncogene 2015 34: 506-515; advance online publication, January 27, 2014; 10.1038/onc.2013.579 Abstract | Full Text Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment A Savar, S Acin, C L Gonzalez, T El-Sawy, O Mejia, Z Li, B Esmaeli, A Lacy-Hulbert, A K El-Naggar, J H McCarty and C Caulin Oncogene 2015 34: 516-524; advance online publication, January 27, 2014; 10.1038/onc.2013.585 Abstract | Full Text Short Communications Top Growth factor receptor/steroid receptor cross talk in trastuzumab-treated breast cancer D C Collins, S Cocchiglia, P Tibbitts, G Solon, F T Bane, J McBryan, A Treumann, A Eustace, B Hennessy, A D Hill and L S Young Oncogene 2015 34: 525-530; advance online publication, January 27, 2014; 10.1038/onc.2013.586 Abstract | Full Text A chromatin modifier genetic screen identifies SIRT2 as a modulator of response to targeted therapies through the regulation of MEK kinase activity P K Bajpe, A Prahallad, H Horlings, I Nagtegaal, R Beijersbergen and R Bernards Oncogene 2015 34: 531-536; advance online publication, January 27, 2014; 10.1038/onc.2013.588 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.